News
By Deena Beasley (Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered ...
9h
MedPage Today on MSNFDA Authorizes AI Platform for Breast Cancer Risk PredictionThe FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...
Often, when young women approach their care teams with concerns about breast cancer, they're brushed aside. It’s our ...
47m
News Medical on MSNTHP regimen achieves high response rates in HER2 positive breast cancer patientsHER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery.
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...
A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...
While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...
The 'Bachelorette' alum shared an update in her ongoing breast cancer struggle as she's "trying to live my best life as a ...
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...
The RHOA personality was diagnosed with stage 1 invasive ductal carcinoma in November 2024. She recently reflected on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results